150
Participants
Start Date
December 9, 2016
Primary Completion Date
April 27, 2018
Study Completion Date
April 27, 2018
Oxybutynin Chloride
Given PO
Placebo
Given PO
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
Waverly Hematology Oncology, Cary
AnMed Health Cancer Center, Anderson
Saint Elizabeth Medical Center South, Edgewood
Michigan Cancer Research Consortium NCORP, Ann Arbor
Oncology Associates at Mercy Medical Center, Cedar Rapids
University of Wisconsin Hospital and Clinics, Madison
Saint Vincent Hospital -Green Bay, Green Bay
Marshfield Clinic, Marshfield
Mayo Clinic, Rochester
Rapid City Regional Hospital, Rapid City
Illinois CancerCare-Peoria, Peoria
Carle Cancer Center NCI Community Oncology Research Program, Urbana
Cancer Center of Kansas - Wichita, Wichita
National Cancer Institute (NCI)
NIH
Academic and Community Cancer Research United
OTHER